These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 28390433)

  • 1. Evaluation of the performance of Human Papillomavirus testing in paired urine and clinician-collected cervical samples among women aged over 30 years in Bhutan.
    Tshomo U; Franceschi S; Tshokey T; Tobgay T; Baussano I; Tenet V; Snijders PJ; Gheit T; Tommasino M; Vorsters A; Clifford GM
    Virol J; 2017 Apr; 14(1):74. PubMed ID: 28390433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. VALHUDES: A protocol for validation of human papillomavirus assays and collection devices for HPV testing on self-samples and urine samples.
    Arbyn M; Peeters E; Benoy I; Vanden Broeck D; Bogers J; De Sutter P; Donders G; Tjalma W; Weyers S; Cuschieri K; Poljak M; Bonde J; Cocuzza C; Zhao FH; Van Keer S; Vorsters A
    J Clin Virol; 2018 Oct; 107():52-56. PubMed ID: 30195193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Performance and Diagnostic Accuracy of a Urine-Based Human Papillomavirus Assay in a Referral Population.
    Cuzick J; Cadman L; Ahmad AS; Ho L; Terry G; Kleeman M; Lyons D; Austin J; Stoler MH; Vibat CRT; Dockter J; Robbins D; Billings PR; Erlander MG
    Cancer Epidemiol Biomarkers Prev; 2017 Jul; 26(7):1053-1059. PubMed ID: 28223432
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparison of Two Widely Used Human Papillomavirus Detection and Genotyping Methods, GP5+/6+-Based PCR Followed by Reverse Line Blot Hybridization and Multiplex Type-Specific E7-Based PCR.
    Clifford GM; Vaccarella S; Franceschi S; Tenet V; Umulisa MC; Tshomo U; Dondog B; Vorsters A; Tommasino M; Heideman DA; Snijders PJ; Gheit T
    J Clin Microbiol; 2016 Aug; 54(8):2031-8. PubMed ID: 27225411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of human papillomavirus detections in urine, vulvar, and cervical samples from women attending a colposcopy clinic.
    Sahasrabuddhe VV; Gravitt PE; Dunn ST; Brown D; Allen RA; Eby YJ; Smith K; Zuna RE; Zhang RR; Gold MA; Schiffman M; Walker JL; Castle PE; Wentzensen N
    J Clin Microbiol; 2014 Jan; 52(1):187-92. PubMed ID: 24197879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urine high-risk human papillomavirus testing as an alternative to routine cervical screening: A comparative diagnostic accuracy study of two urine collection devices using a randomised study design trial.
    Davies JC; Sargent A; Pinggera E; Carter S; Gilham C; Sasieni P; Crosbie EJ
    BJOG; 2024 Oct; 131(11):1456-1464. PubMed ID: 38660737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of high-risk human papillomavirus types PCR detection in paired urine and cervical samples of women with abnormal cytology.
    Daponte A; Pournaras S; Mademtzis I; Hadjichristodoulou C; Kostopoulou E; Maniatis AN; Messinis IE
    J Clin Virol; 2006 Jul; 36(3):189-93. PubMed ID: 16690350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human papillomavirus testing on self-collected samples to detect high-grade cervical lesions in rural Bhutan: The REACH-Bhutan study.
    Clifford GM; Baussano I; Heideman DAM; Tshering S; Choden T; Lazzarato F; Tenet V; Franceschi S; Darragh TM; Tobgay T; Tshomo U
    Cancer Med; 2023 May; 12(10):11828-11837. PubMed ID: 36999740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and analytical evaluation of the RealTime High Risk HPV assay in Colli-Pee collected first-void urine using the VALHUDES protocol.
    Van Keer S; Peeters E; Vanden Broeck D; De Sutter P; Donders G; Doyen J; Tjalma WAA; Weyers S; Vorsters A; Arbyn M
    Gynecol Oncol; 2021 Sep; 162(3):575-583. PubMed ID: 34172287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HPV testing in first-void urine provides sensitivity for CIN2+ detection comparable with a smear taken by a clinician or a brush-based self-sample: cross-sectional data from a triage population.
    Leeman A; Del Pino M; Molijn A; Rodriguez A; Torné A; de Koning M; Ordi J; van Kemenade F; Jenkins D; Quint W
    BJOG; 2017 Aug; 124(9):1356-1363. PubMed ID: 28391609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical validation of the HPV-risk assay, a novel real-time PCR assay for detection of high-risk human papillomavirus DNA by targeting the E7 region.
    Hesselink AT; Berkhof J; van der Salm ML; van Splunter AP; Geelen TH; van Kemenade FJ; Bleeker MG; Heideman DA
    J Clin Microbiol; 2014 Mar; 52(3):890-6. PubMed ID: 24391196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Performance and Diagnostic Accuracy of Human Papillomavirus Testing on Self-Collected Urine and Vaginal Samples in a Referral Population.
    Cho HW; Hong JH; Min KJ; Ouh YT; Seong SJ; Moon JH; Cho SH; Lee JK
    Cancer Res Treat; 2021 Jul; 53(3):829-836. PubMed ID: 33421987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Self-collected versus clinician-collected cervical samples for the detection of HPV infections by 14-type DNA and 7-type mRNA tests.
    Aranda Flores CE; Gomez Gutierrez G; Ortiz Leon JM; Cruz Rodriguez D; Sørbye SW
    BMC Infect Dis; 2021 May; 21(1):504. PubMed ID: 34058992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Self-sampling with HPV mRNA analyses from vagina and urine compared with cervical samples.
    Asciutto KC; Ernstson A; Forslund O; Borgfeldt C
    J Clin Virol; 2018 Apr; 101():69-73. PubMed ID: 29433016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of urine, self-collected vaginal swab, and cervical swab samples for detecting human papillomavirus (HPV) with Roche Cobas HPV, Anyplex II HPV, and RealTime HR-S HPV assay.
    Cho HW; Ouh YT; Hong JH; Min KJ; So KA; Kim TJ; Paik ES; Lee JW; Moon JH; Lee JK
    J Virol Methods; 2019 Jul; 269():77-82. PubMed ID: 30998958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interest of human papillomavirus DNA quantification and genotyping in paired cervical and urine samples to detect cervical lesions.
    Ducancelle A; Legrand MC; Pivert A; Veillon P; Le Guillou-Guillemette H; De Brux MA; Beby-Defaux A; Agius G; Hantz S; Alain S; Catala L; Descamps P; Postec E; Caly H; Charles-Pétillon F; Labrousse F; Lunel F; Payan C
    Arch Gynecol Obstet; 2014 Aug; 290(2):299-308. PubMed ID: 24622934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the analytical and clinical performance of five tests for the detection of human papillomavirus genital infection.
    Del Pino M; Alonso I; Rodriguez-Trujillo A; Bernal S; Geraets D; Guimerà N; Torne A; Ordi J
    J Virol Methods; 2017 Oct; 248():238-243. PubMed ID: 28739302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical performance of the HPV-Risk assay on cervical samples in SurePath medium using the VALGENT-4 panel.
    Heideman DAM; Xu L; Hesselink AT; Doorn S; Ejegod DM; Pedersen H; Quint WGV; Bonde J; Arbyn M
    J Clin Virol; 2019 Dec; 121():104201. PubMed ID: 31629967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic Performance of HPV E6/E7 mRNA and HPV DNA Assays for the Detection and Screening of Oncogenic Human Papillomavirus Infection among Woman with Cervical Lesions in China.
    Wang HY; Lee D; Park S; Kim G; Kim S; Han L; Yubo R; Li Y; Park KH; Lee H
    Asian Pac J Cancer Prev; 2015; 16(17):7633-40. PubMed ID: 26625774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of first-void urine with Aptima Transfer Solution increases detection of high-risk HPV E6/E7 mRNA.
    Arias M; Jang D; Dockter J; Ratnam S; Shah A; Elit L; Smieja M; Lytwyn A; Getman D; Weinbaum B; Chernesky M
    J Virol Methods; 2019 May; 267():48-52. PubMed ID: 30797768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.